巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    DURECT Corp

    DRRX
    0.670
    ▲0.010
    ▲1.95%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・DURECT Corp - 延遲價格・最後更新於 10/08 2:10
    最高位
    0.670
    最低位
    0.670
    開市價
    --
    前收市價
    0.657
    成交量(千)
    0.20
    成交額(百萬)
    0.00
    買入
    0.668
    賣出
    0.688
    每手股數
    --
    市值(百萬)
    152.62
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.440 - 0.360
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    DURECT Corp
    證券代碼
    DRRX.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.
    發行量
    227764019
    公司總部
    10260 Bubb Road
    公司網址
    http://www.durect.com
    公司電郵
    mike.arenberg@durect.com
    公司電話
    +1 408 777-1417

    最新發佈

    暫無內容

    關於

    DURECT Corp(DRRX.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.
    詳細公司背景可參考: http://www.durect.com。